UnitedHealth Group's 15% Gain Leaves Room for Further Upside

UnitedHealth Group's stock has risen by 15.4% year to date, but valuation checks still suggest it is undervalued rather than fully priced.

The sale of an interest in certain Florida WellMed clinics to TPG may support capital efficiency and margin repair, while execution risks around the wider Optum turnaround and cost pressures can weigh on investors' willingness to pay.

On Simply Wall St's composite scorecard, UnitedHealth Group screens as undervalued, with a high value score of 6 that points to broadly supportive readings across core checks.

The issue now is whether the current price level still leaves enough upside potential to justify fresh capital going into UnitedHealth Group today.